STOCK TITAN

Auxly Cannabis - CBWTF STOCK NEWS

Welcome to our dedicated page for Auxly Cannabis news (Ticker: CBWTF), a resource for investors and traders seeking the latest updates and insights on Auxly Cannabis stock.

About Auxly Cannabis Group Inc. (TSX: XLY, OTCQB: CBWTF)

Auxly Cannabis Group Inc. is a leading Canadian consumer-packaged goods (CPG) company specializing in cannabis products. Headquartered in Toronto, Auxly operates across the full cannabis value chain, focusing on cultivating, processing, and distributing a diverse portfolio of high-quality cannabis products. The company’s mission is to help consumers live happier lives through trusted and innovative cannabis solutions.

Core Business and Product Portfolio

Auxly’s product portfolio spans key categories, including dried flower, pre-rolls, vapes, oils, and other Cannabis 2.0 products. The company has established itself as a leading player in the Canadian recreational cannabis market, leveraging its advanced cultivation facility, Auxly Leamington, to produce high-quality cannabis at a competitive cost. Auxly’s flagship brands, such as Back Forty and Kolab Project, are recognized for their innovative formats and consumer-centric designs, particularly in the fast-growing vape and pre-roll segments.

Operational Excellence and Market Position

Auxly’s operational strategy is underpinned by its vertically integrated model, which allows the company to control every aspect of production, from cultivation to distribution. The Auxly Leamington facility, a state-of-the-art greenhouse, serves as a cornerstone of the company’s low-cost cultivation strategy. This facility has enabled Auxly to achieve industry-leading gross margins and consistently meet the demands of both retail and wholesale markets.

In the competitive Canadian cannabis landscape, Auxly has secured a top-five position among licensed producers by retail sales. The company’s focus on efficiency and innovation has driven significant market share gains, particularly in the all-in-one vape category, where its Back Forty brand holds a dominant position. Auxly’s products are distributed nationwide, including in Quebec, marking a significant milestone in its expansion strategy.

Innovation and Consumer-Centric Approach

Auxly is committed to product innovation, continuously enhancing its offerings to meet evolving consumer preferences. Recent launches include advanced pre-roll formats and all-in-one vape hardware with customizable features. The company’s emphasis on quality, safety, and efficacy has fostered strong consumer trust and loyalty, positioning Auxly as a preferred choice in the Canadian cannabis market.

Financial Performance and Strategic Growth

Auxly has demonstrated a strong financial trajectory, achieving record-breaking revenues and adjusted EBITDA in recent quarters. The company’s focus on sustainable growth, operational efficiency, and cost management has resulted in improved profitability and cash flow. Strategic initiatives, such as the conversion of debt into equity by Imperial Brands, have further strengthened Auxly’s financial position, enabling it to invest in future growth opportunities.

Challenges and Competitive Landscape

Despite its successes, Auxly operates in a challenging environment characterized by regulatory complexities, price compression, and competition from both legal and illicit markets. The company addresses these challenges through its low-cost cultivation model, innovative product development, and strategic partnerships. Auxly’s ability to adapt and thrive in this dynamic market underscores its resilience and commitment to long-term success.

Future Outlook

Looking ahead, Auxly remains focused on driving sustainable growth and profitability. The company plans to expand its product portfolio, deepen relationships with key retail partners, and optimize its operational efficiencies. With a strong foundation in place, Auxly is well-positioned to capitalize on the evolving cannabis market and deliver value to its stakeholders.

Conclusion

Auxly Cannabis Group Inc. stands out as a dynamic and innovative player in the Canadian cannabis industry. Through its commitment to quality, operational excellence, and consumer satisfaction, Auxly continues to set benchmarks for success in the competitive cannabis market.

Rhea-AI Summary

Auxly Cannabis Group (OTCQB: CBWTF) reported record-breaking Q3 2024 financial results with net revenues of $33.3 million, up 18% year-over-year. The company achieved a gross margin of 47% and record adjusted EBITDA of $8.3 million. Net income was $3.2 million with operating cash flow of $12.9 million. The company reduced its debt by 54% compared to end of 2023. Auxly moved to #4 position in national recreational sales, leading the all-in-one vape category with 36% market share. Back Forty's Liquid Imagination became the #1 selling flower nationally, while pre-roll sales increased 19% quarter-over-quarter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.51%
Tags
-
Rhea-AI Summary

Auxly Cannabis Group (TSX: XLY) (OTCQB: CBWTF) has announced it will release its third quarter 2024 financial results on Friday, November 8, 2024, before market open. The results will cover the period ended September 30, 2024. The company has directed all investor inquiries to IR@auxly.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.49%
Tags
conferences earnings
-
Rhea-AI Summary

Auxly Cannabis Group reported record revenue and profitability for Q2 2024. Net revenues reached $29.2 million, a 33% increase year-over-year and a 16% rise from the previous quarter. Gross Margin on Finished Cannabis Inventory Sold hit an all-time high of 41%, a 14% improvement year-over-year. Adjusted EBITDA surged by over 580% to $5.2 million. SG&A expenses were slightly reduced by $0.2 million compared to the same period in 2023, net of restructuring costs. Net income stood at $2.0 million, with positive cash flow from operations of $2.9 million. The company reported a 48% reduction in debt compared to the end of 2023. Auxly maintained its market leadership in the all-in-one vape category, securing over 32% of the total market share. The Back Forty brand continued to dominate with the top four all-in-one vape SKUs and achieved strong performance in dried flower and pre-rolls. Despite the gains, Auxly reported a net loss of $24.0 million for the six months ended June 30, 2024, including deferred tax expenses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) has announced that it will release its second quarter 2024 financial results on Thursday, August 15, 2024, before the financial markets open. The report will cover the period ended June 30, 2024. This announcement serves as a notice to investors and analysts who are interested in the company's financial performance. Auxly has directed all investor inquiries to be sent to IR@auxly.com. The announcement was made by CEO Hugo Alves on behalf of the board.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.7%
Tags
conferences earnings
-
Rhea-AI Summary

Auxly Cannabis Group (TSX: XLY, OTCQB: CBWTF) announced the results of its annual general and special meeting of shareholders held on June 28, 2024. Over 407 million shares, representing 32.55% of the outstanding common shares, were voted. All proposals presented were approved, including the re-appointment of Ernst & Young LLP as auditors and the re-approval of the 2021 Equity Incentive Plan, which passed with 86.21% of the votes. Directors Genevieve Young, Hugo Alves, Troy Grant, Vikram Bawa, and Conrad Tate were re-elected. The Share Consolidation Resolution was removed from the agenda. Detailed voting results are available on SEDAR.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.7%
Tags
none
-
Rhea-AI Summary

Auxly Cannabis Group announced its Annual General Meeting of Shareholders on June 28, 2024, at 10:00 a.m. EST, at McCarthy Tétrault LLP, Toronto. Due to seating, shareholders must pre-register by emailing IR@auxly.com at least 48 hours before the meeting. An audio teleconference will be available for real-time listening. Shareholders are encouraged to vote in advance as teleconference participants cannot vote or otherwise participate in the meeting. Additional meeting details are in the Management Information Circular, accessible on SEDAR+ and the company's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
none
Rhea-AI Summary

Auxly Cannabis Group Inc. reported record financial results for Q1 2024 with net revenues of $25.2 million, a 5% increase from the same period in 2023. The company achieved a gross margin of 38% and an adjusted EBITDA of $2.2 million, a 1,523% improvement year-over-year. Auxly reduced SG&A costs by 11% and strengthened its balance sheet through debt conversion. The company maintained its top 10 LP position in Canada and continued to lead in the vapor category and pre-roll market. Additionally, Auxly expanded product offerings to Quebec and introduced new 0.75g pre-rolls.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.91%
Tags
-
Rhea-AI Summary

Auxly Cannabis Group Inc. (CBWTF) will release its first-quarter 2024 financial results on May 13, 2024. The report will cover earnings for the period ending on March 31, 2024. Investors can expect the release before the markets open, with inquiries directed to IR@auxly.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Summary

Auxly Cannabis Group Inc. expands into Quebec, launching new pre-roll and vape products, including Back Forty slim style pre-rolls and innovative vape hardware. The company introduces Liquid Imagination cultivar and new flavour profiles like White Freeze and Kolab Project. Auxly aims to capture the Quebec market, strengthen national presence, and cater to evolving consumer needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.44%
Tags
none
Rhea-AI Summary
Auxly Cannabis Group Inc. announces the conversion of $123 million in debt to shares by Imperial Brands plc, resulting in a 19.8% ownership stake. The move eliminates debt, reduces annual expenses, and strengthens the company's financial position.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.11%
Tags
none

FAQ

What is the current stock price of Auxly Cannabis (CBWTF)?

The current stock price of Auxly Cannabis (CBWTF) is $0.06 as of February 28, 2025.

What is the market cap of Auxly Cannabis (CBWTF)?

The market cap of Auxly Cannabis (CBWTF) is approximately 56.9M.

What does Auxly Cannabis Group specialize in?

Auxly specializes in producing and distributing cannabis products, including dried flower, pre-rolls, vapes, and oils, for the Canadian recreational market.

What is Auxly’s competitive advantage?

Auxly’s competitive advantage lies in its low-cost cultivation facility, Auxly Leamington, and its focus on innovation and operational efficiency.

What are Auxly’s key product categories?

Auxly’s key product categories include dried flower, pre-rolls, vapes, oils, and other Cannabis 2.0 products.

How does Auxly generate revenue?

Auxly generates revenue through retail sales to provincial distributors and wholesale bulk cannabis sales to other industry participants.

What is Auxly’s market position in Canada?

Auxly is one of the top licensed producers in Canada by retail sales, with a strong presence in the vape and pre-roll segments.

What challenges does Auxly face in the cannabis market?

Auxly faces challenges such as regulatory pressures, price compression, and competition from both legal and illicit markets.

What role does innovation play in Auxly’s strategy?

Innovation is central to Auxly’s strategy, as the company continuously develops advanced product formats to meet evolving consumer preferences.

Who are Auxly’s strategic partners?

Auxly’s key strategic partner is Imperial Brands, which has supported the company’s growth through equity investments and collaboration.

What is Auxly’s financial outlook?

Auxly is focused on sustainable growth, profitability, and operational efficiency, with a strong financial position to support future initiatives.

What is Auxly’s mission?

Auxly’s mission is to help consumers live happier lives by providing high-quality, trusted cannabis products.
Auxly Cannabis

OTC:CBWTF

CBWTF Rankings

CBWTF Stock Data

56.95M
1.01B
21.34%
0.24%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Toronto